TruSpine Technologies PLC Further re Bridge Loan Facility & Letter of Intent (2324P)
08 Fevereiro 2023 - 5:00AM
UK Regulatory
TIDMTSP
RNS Number : 2324P
TruSpine Technologies PLC
08 February 2023
8 February 2023
TruSpine Technologies plc
("TruSpine" or the "Company")
Further re Bridge Loan Facility and Letter of Intent
TruSpine Technologies Plc, the medical device company focused on
the spinal (vertebral) stabilisation market, provides an update in
relation to the announcement made on 1 February 2023 concerning the
Bridge Loan and LOI entered into with the Investment Group to
provide the Company with staged equity funding.
The Company requested the drawdown from the GBP200,000 Bridge
Loan facility that was notified on 3 January 2023, however, these
funds have not yet been received, the Company expects receipt of
these funds shortly.
The subscription for Tranche 1 of the staged equity funding is
expected to be subscribed for on or before 17 February 2023.
As previously notified, in the event that the Bridge Loan
facility does not complete successfully and the equity drawdown
funds are not received, the Company will need to raise further
capital in the short term. The Company continues to carefully
manage its working capital.
Capitalised terms used in this announcement shall, unless
otherwise defined, have the same meanings as set out in the
Company's announcement of 3 January 2023.
This announcement contains inside information for the purposes
of the UK Market Abuse Regulation, and the Directors of the Company
are responsible for the release of this announcement.
Enquiries:
TruSpine Technologies Plc Tel: +44 (0)20 3638 5025
Ian Roberts, CEO
Cairn Financial Advisers LLP (AQSE Corporate Adviser) Tel: +44 (0)20 7213 0880
Liam Murray / Ludovico Lazzaretti
Oberon Capital (Joint Broker) Tel: +44 (0)20 3179 5300
Mike Seabrook / Chris Crawford
Peterhouse Capital Limited (Joint Broker & Financial Adviser)
Tel: +44 (0)20 7469 0930
Lucy Williams / Duncan Vasey
Walbrook PR (Financial PR & IR) Tel: +44 (0) 20 7933 7870 or +44 (0) 7876 741 001
Anna Dunphy truspine@walbrookpr.com
Caution regarding forward looking statements
Certain statements in this announcement, are, or may be deemed
to be, forward looking statements. Forward looking statements are
identi ed by their use of terms and phrases such as "believe",
"could", "should" "envisage", "estimate", "intend", "may", "plan",
"potentially", "expect", "will" or the negative of those,
variations or comparable expressions, including references to
assumptions. These forward-looking statements are not based on
historical facts but rather on the Directors' current expectations
and assumptions regarding the Company's future growth, results of
operations, performance, future capital and other expenditures
(including the amount, nature and sources of funding thereof),
competitive advantages, business prospects and opportunities. Such
forward looking statements re ect the Directors' current beliefs
and assumptions and are based on information currently available to
the Directors.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NEXEAAAXEENDEAA
(END) Dow Jones Newswires
February 08, 2023 03:00 ET (08:00 GMT)
TruSpine Technologies (AQSE:TSP)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
TruSpine Technologies (AQSE:TSP)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
